Many independent doctors and researchers are skeptical, saying the new conditions are the product of medical groups that get pharmaceutical industry funding, researchers looking to advance their careers and drug companies aiming to broaden the market for expensive new products. On top of that, the drugs sold to treat these newly defined — and not life-threatening — conditions often carry serious health risks.
Read Full Article »
